Midgard Science

Labs / CDMO: development & manufacturing

Molecular Partners

Zurich, Switzerland · molecularpartners.com

On your own

Free. Their own form.

Contact Molecular Partners directly

Through Midgard

Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.

Request a quote through Midgard

Molecular Partners develops DARPin therapeutics for people with cancer and other serious diseases. The company is based in Zurich-Schlieren, Switzerland, with a U.S. office in Cambridge, Massachusetts, and also lists a secondary address in Concord, Massachusetts.

They take quote requests by email.

What they offer

  • DARPin therapeutics discovery and development

    Develops custom-built DARPin drugs using in-house design and development expertise with world-class partners.

  • Radio-DARPin therapy development

    Creates radiopharmaceutical DARPin programs for targeted radiotherapy, including programs against DLL3 and MSLN.

  • Switch-DARPin development

    Develops logic-gated immune cell engagers for targeted and conditional immune activation.

  • Multispecific immuno-oncology program development

    Develops multispecific therapeutics such as FAP x CD40 agonists for tumor-localized immune activation.

What they work on

Modalities
Antibody, Bispecific
Therapeutic areas
cancer, serious diseases, ovarian cancer, small cell lung cancer
Sites
Zurich-Schlieren, Switzerland · Cambridge, Massachusetts, United States
Address
245 Main Street Cambridge, MA 02142
Founded
2022

Public records

Ownership
Molecular Partners AG · CH GLEIF

Similar labs. 3C Therapeutics, Accellix, Adragos Pharma, AGC Biologics

Found in a contract services directory. Listing built from molecularpartners.com. Work here? Claim this listing.

Molecular Partners · Midgard Science